Immune Thrombocytopenia (ITP) in Pregnancy: “Can’t-Miss” Points

Immune thrombocytopenia (ITP) is a complex autoimmune disorder characterized by low platelet counts, which presents significant clinical challenges when it occurs during pregnancy. This podcast discusses how the condition is driven by antiplatelet antibodies that can cross the placenta, potentially affecting both maternal health and fetal development. Distinguishing ITP from more common conditions like gestational thrombocytopenia is essential for determining the appropriate medical response and monitoring schedule. Standard treatments typically involve prednisone and intravenous immune globulin, though newer options like thrombopoietin-receptor agonists are increasingly considered for difficult cases. Management requires a coordinated team of specialists to balance the risks of hemorrhage against the safety of medications during gestation and delivery. Ultimately, while ITP complicates pregnancy, careful risk assessment and individualized therapy usually lead to successful outcomes for both mother and child.